# IQVIA (IQV) — Analyst Forecast

IQV · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/iqv/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 20 | 5 | 0 | 25 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $270.00 | $299.64 | $345.00 | 11 |

Last price $271.04 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | Stifel | Maintained | Buy | $303.00 |
| Oct 7, 2026 | Barclays | Maintained | Overweight | $300.00 |
| Oct 7, 2026 | Mizuho | Maintained | Outperform | $300.00 |
| Sep 30, 2026 | UBS | Maintained | Buy | $345.00 |
| Sep 29, 2026 | RBC Capital | Maintained | Outperform | $319.00 |
| Sep 28, 2026 | Truist Securities | Maintained | Buy | $329.00 |
| Sep 17, 2026 | Morgan Stanley | Maintained | Equal-Weight | $270.00 |
| Jul 29, 2026 | Baird | Maintained | Outperform | $287.00 |
| Jul 29, 2026 | BMO Capital | Maintained | Outperform | $270.00 |
| Jul 29, 2026 | RBC Capital | Maintained | Outperform | $247.00 |
| Jul 29, 2026 | TD Cowen | Maintained | Buy | $288.00 |
| Jul 29, 2026 | Stifel | Maintained | Buy | $276.00 |
| Jul 29, 2026 | JP Morgan | Maintained | Overweight | $285.00 |
| Jul 13, 2026 | Mizuho | Maintained | Outperform | $230.00 |
| Jul 1, 2026 | Baird | Maintained | Outperform | $249.00 |
| Jun 17, 2026 | Morgan Stanley | Downgraded | Overweight → Equal-Weight | $200.00 |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | $185.00 |
| Mar 9, 2026 | TD Cowen | Upgraded | Hold → Buy | $213.00 |
| Mar 6, 2026 | Barclays | Upgraded | Equal-Weight → Overweight | $210.00 |
| Mar 3, 2026 | RBC Capital | Initiated Coverage | Outperform | $221.00 |

## Frequently Asked Questions

### What is the price target for IQV stock?

The average 12-month analyst price target for IQVIA (IQV) is $299.64, with a high estimate of $345.00 and a low of $270.00, across 11 analysts.

### Is IQV a buy, sell, or hold?

Analysts covering IQVIA currently average a Buy rating: 20 buy, 5 hold and 0 sell, from 25 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for IQV?

The average price target of $299.64 implies 10.55% upside from the last price of $271.04.

### What is the latest analyst rating on IQV?

On Oct 14, 2026, Stifel maintained IQVIA at Buy with a price target of $303.00.

## Similar Stocks

- [CRL](https://www.lighthorse.io/tickers/crl) — Charles River Laboratories International, Inc. Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [ICLR](https://www.lighthorse.io/tickers/iclr) — ICON plc - Ordinary Shares
- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock
- [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock
- [MTD](https://www.lighthorse.io/tickers/mtd) — Mettler-Toledo International, Inc. Common Stock
- [TECH](https://www.lighthorse.io/tickers/tech) — Bio-Techne Corp - Common Stock
- [WAT](https://www.lighthorse.io/tickers/wat) — Waters Corporation Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).